CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 
 

CBPO's Income from Cont. Operations Growth by Quarter and Year

China Biologic Products Holdings Inc 's Income from Cont. Operations results by quarter and year




CBPO Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 163.40 147.97 82.24 23.18
III Quarter September - - - 35.39
II Quarter June - - 34.84 37.49
I Quarter March - - 34.34 32.73
FY   163.40 147.97 151.42 128.79



CBPO Income from Cont. Operations forth quarter 2019 Y/Y Growth Comment
China Biologic Products Holdings Inc reported Income from Cont. Operations increase of 10.42% year on year in the forth quarter 2019, to $ 163.40 millions, this is lower than China Biologic Products Holdings Inc 's recent average Income from Cont. Operations increase of 14.51%.

Looking into forth quarter 2019 results within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Income from Cont. Operations growth. While China Biologic Products Holdings Inc ' s Income from Cont. Operations growth of 10.42% ranks overall at the positon no. 979 in the forth quarter 2019.




CBPO Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December 10.42 % 79.92 % 254.79 % 14.02 %
III Quarter September - - - 18.44 %
II Quarter June - - -7.07 % 9.49 %
I Quarter March - - 4.92 % 10.35 %
FY   10.42 % -2.28 % 17.57 % 12.86 %

Financial Statements
China Biologic Products Holdings Inc 's forth quarter 2019 Income from Cont. Operations $ 163.40 millions CBPO's Income Statement
China Biologic Products Holdings Inc 's forth quarter 2018 Income from Cont. Operations $ 147.97 millions Quarterly CBPO's Income Statement
New: More CBPO's historic Income from Cont. Operations Growth >>


CBPO Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -34.5 %
III Quarter September - - - -5.6 %
II Quarter June - - 1.46 % 14.54 %
I Quarter March - - 48.14 % 60.99 %
FY (Year on Year)   10.42 % -2.28 % 17.57 % 12.86 %




Income from Cont. Operations forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #81
Overall #979

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
254.77 % 14.51 % -100 %
(Dec 31 2017)   0
Income from Cont. Operations forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #81
Overall #979
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
254.77 % 14.51 % -100 %
(Dec 31 2017)   0

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

China Biologic Products Holdings Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
115.08 % -2.8 % -100 %
(Mar 31 2013)  


CBPO's IV. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
115.08 % -2.8 % -100 %
(Mar 31 2013)  


CBPO's IV. Quarter Q/Q Income from Cont. Operations Comment


China Biologic Products Holdings Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Income from Cont. Operations 12 Months Ending $ 163.40 $ 147.97 $ 82.24 $ 127.74 $ 130.40
Y / Y Income from Cont. Operations Growth (TTM) 10.43 % 79.93 % 254.77 % 6.07 % 11.28 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 1006 # 0 # 0 # 0 # 349
Seqeuential Income from Cont. Operations Change (TTM) 10.43 % 79.93 % 254.77 % -2.04 % 1.25 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 753 # 0 # 0 # 0 # 268




Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Dec 31 2019 period, China Biologic Products Holdings Inc 's cumulative twelve months Income from Cont. Operations were $ 163 millions, company would post below average annual Income from Cont. Operations growth of 1.25% year on year, if the fiscal year would end at Dec 31 2019.
A slow-down in the China Biologic Products Holdings Inc 's Income from Cont. Operations growth from the 0% growth in Dec 31 2018.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 1006.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
254.77 %
22.21 %
-2.04 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 80
Overall # 1006

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
254.77 %
34.15 %
6.07 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 56
S&P 500 # 753
Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Dec 31 2019 period, China Biologic Products Holdings Inc 's cumulative twelve months Income from Cont. Operations were $ 163 millions, company would post below average annual Income from Cont. Operations growth of 6.07% year on year, if the fiscal year would end at Dec 31 2019.
A slow-down in the China Biologic Products Holdings Inc 's Income from Cont. Operations growth from the 0% growth in Dec 31 2018.

In the Healthcare sector 79 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 1006.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
254.77 %
22.21 %
-2.04 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 80
Overall # 1006

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
254.77 %
34.15 %
6.07 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 56
S&P 500 # 753




Other Income from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
CBPO's Income from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for CBPO's Competitors
Income from Cont. Operations Growth for China Biologic Products Holdings Inc 's Suppliers
Income from Cont. Operations Growth for CBPO's Customers

You may also want to know
CBPO's Annual Growth Rates CBPO's Profitability Ratios CBPO's Asset Turnover Ratio CBPO's Dividend Growth
CBPO's Roe CBPO's Valuation Ratios CBPO's Financial Strength Ratios CBPO's Dividend Payout Ratio
CBPO's Roa CBPO's Inventory Turnover Ratio CBPO's Growth Rates CBPO's Dividend Comparisons



Companies with similar Income from Cont. Operations growth for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2019
Masimo Corp12.76%$ 12.756 millions
Zynex inc.12.40%$ 12.395 millions
Citrine Global Corp11.97%$ 11.972 millions
National Research Corporation11.50%$ 11.499 millions
China Biologic Products Holdings Inc 10.43%$ 10.427 millions
Biospecifics Technologies Corp9.25%$ 9.254 millions
Grifols Sa9.12%$ 9.125 millions
Redhill Biopharma Ltd 8.97%$ 8.975 millions
Mettler Toledo International Inc6.38%$ 6.382 millions
Pro dex Inc.5.94%$ 5.937 millions
Purple Biotech Ltd 5.82%$ 5.818 millions
Idexx Laboratories Inc5.68%$ 5.681 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

XM's Profile

Stock Price

XM's Financials

Business Description

Fundamentals

Charts & Quotes

XM's News

Suppliers

XM's Competitors

Customers & Markets

Economic Indicators

XM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071